Trial · NCT00267748
Participant flow21
How many started, completed or left each group, period by period.
1 to 20 of 21
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Non-randomized Period | STARTED | Sunitinib 37.5 mg + Interferon Alpha-2b | 25 | |
| Non-randomized Period | STARTED | Sunitinib 50 mg (Schedule 4/2) | 0 | |
| Non-randomized Period | STARTED | Sunitinib 37.5 mg | 0 | |
| Non-randomized Period | COMPLETED | Sunitinib 37.5 mg + Interferon Alpha-2b | 2 | |
| Non-randomized Period | COMPLETED | Sunitinib 50 mg (Schedule 4/2) | 0 | |
| Non-randomized Period | COMPLETED | Sunitinib 37.5 mg | 0 | |
| Non-randomized Period | NOT COMPLETED | Sunitinib 37.5 mg + Interferon Alpha-2b | 23 | |
| Non-randomized Period | NOT COMPLETED | Sunitinib 50 mg (Schedule 4/2) | 0 | |
| Non-randomized Period | NOT COMPLETED | Sunitinib 37.5 mg | 0 | |
| Randomized Period | STARTED | Sunitinib 37.5 mg + Interferon Alpha-2b | 0 | |
| Randomized Period | STARTED | Sunitinib 50 mg (Schedule 4/2) | 146 | |
| Randomized Period | STARTED | Sunitinib 37.5 mg | 146 | |
| Randomized Period | Treated | Sunitinib 37.5 mg + Interferon Alpha-2b | 0 | |
| Randomized Period | Treated | Sunitinib 50 mg (Schedule 4/2) | 146 | |
| Randomized Period | Treated | Sunitinib 37.5 mg | 143 | |
| Randomized Period | COMPLETED | Sunitinib 37.5 mg + Interferon Alpha-2b | 0 | |
| Randomized Period | COMPLETED | Sunitinib 50 mg (Schedule 4/2) | 19 | |
| Randomized Period | COMPLETED | Sunitinib 37.5 mg | 14 | |
| Randomized Period | NOT COMPLETED | Sunitinib 37.5 mg + Interferon Alpha-2b | 0 | |
| Randomized Period | NOT COMPLETED | Sunitinib 50 mg (Schedule 4/2) | 127 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00267748/flow